BOSTON, MA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)ORGANIZING NETWORKING EVENTS WHERE BIOTECH, PHARMA, MEDTECH, DIAGNOSTIC AND VENTURE CAPITAL EXECUTIVES CAN BUILD RELATIONSHIPS, SOURCE TRANSACTIONS AND LEARN ABOUT OTHER COMPANIES IN THEIR AREA, FOSTERING A STRONGER ENVIRONMENT FOR THE LIFE SCIENCES.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2021 | 2020 | Change | |
|---|---|---|---|
| Revenue | N/A | $66,000 | -1.0% |
| Expenses | N/A | $117,217 | -1.0% |
| Net Income | N/A | $-51,217 | N/A |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| ROBERTA MEYERSON | DIRECTOR | 0.25 |
Director
|
$0 | $0 | $0 |
| ANDREW MEYERSON | DIRECTOR | 0.25 |
Director
|
$0 | $0 | $0 |
| MARTIN LEHR | SECRETARY | 0.25 |
Officer
Director
|
$0 | $0 | $0 |
| GEOFFREY MEYERSON | PRESIDENT/TREASURER | 0.25 |
Officer
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2022 | No data | No data | No data | No data |
| 2021 | $66,000 | $117,217 | $6,515 | $-51,217 |
| 2020 | $86,700 | $215,711 | $113,414 | $-129,011 |
| 2019 | $292,180 | $232,857 | $275,384 | $59,323 |
| 2018 | $263,600 | $213,614 | $235,117 | $49,986 |
Compare THE BIOBREAK ORGANIZATION INC with other nonprofits in Massachusetts and across the country.